Forendo Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Forendo Therapeutics's estimated annual revenue is currently $4.3M per year.
- Forendo Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Forendo Therapeutics has 28 Employees.
- Forendo Therapeutics grew their employee count by -26% last year.
Forendo Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Business Development | Reveal Email/Phone |
3 | Project Director | Reveal Email/Phone |
Forendo Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Forendo Therapeutics?
At Forendo, we are pioneering the translation of intracrinology science into first-in-class therapeutic solutions. Intracrinology enables us to address diseases on an unprecedented tissue specific level. Our lead clinical compound in endometriosis addresses a significant unmet need through its local effect on endometriotic lesions. Our second program is targeting polycystic ovarian syndrome (PCOS) which has no approved therapies. In addition to women's health programs, Forendo has a strategic collaboration with Novartis leveraging our unique HSD17B platform in chronic liver diseases. We are based in Finland and backed by leading life science investors.
keywords:N/A
N/A
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
-26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Forendo Therapeutics News
... Takeda Pharmaceutical Company Limited, Addex Therapeutics, Sanofi, ... Philogen, Repros Therapeutics Inc., Abbvie Inc., Forendo Pharma.
AbbVie, AstraZeneca, Bayer HealthCare, Pfizer, Addex Therapeutics, Astellas Pharma, Debiopharm, ElexoPharm, EndoCeutics, Euroscreen, Forendo...
Other Companies in Turku
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.8M | 28 | 33% | N/A |
#2 | $2.8M | 29 | N/A | N/A |
#3 | $2M | 29 | 38% | N/A |
#4 | $3.5M | 30 | 11% | N/A |
#5 | N/A | 31 | 41% | N/A |